QHM-2025-3620 Express Diagnostics Limited - ECG Interpretation & Holter Monitoring

The NHS North East and North Cumbria Integrated Care Board has concluded the procurement process for the contract titled "QHM-2025-3620 Express Diagnostics Limited - ECG Interpretation & Holter Monitoring," which falls under the industry category of Medical Analysis Services. This procurement is characterised as a services contract and was executed under Health Care Services (Provider Selection Regime) Regulations 2023. The direct award process was used to appoint the existing service provider, Express Diagnostics (Cardio Analytics), to continue delivering the specified medical services.

The procurement process began with an intention to award notice dated 4th August 2025, and the formal award was confirmed on 16th July 2025. The contract is active, with a value of £321,615, and covers the period from 1st April 2025 to 31st March 2026. The procurement process did not involve prior publication of a call for competition, typical of a limited procurement method, and is localised in the Sunderland region of the United Kingdom.

This procurement tender presents significant business growth opportunities, particularly for businesses capable of delivering high-quality medical analysis services. Firms specialising in ECG interpretation and Holter monitoring systems, especially those proficient under similar provider selection regimes, stand to benefit most. The contract structure favours businesses with proven track records, particularly existing service providers who have demonstrated their ability to satisfy the requirements effectively.

Such opportunities are ideal for medium to large healthcare service providers looking to expand their footprint in the UK healthcare market, particularly in the North East and North Cumbria regions. By aligning with the procurement regulations and maintaining excellence in service delivery, eligible businesses can leverage such contracts to enhance their market presence and operational capabilities.